MedPath

YALE UNIVERSITY

YALE UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1701-10-09
Employees
10K
Market Cap
-
Website
http://www.yale.edu

COVID-19 Vaccination Reduces Severe Kidney Damage Risk in Hospitalized Patients, UCLA Study Finds

UCLA Health researchers analyzed 3,500 hospitalized COVID-19 patients and found unvaccinated individuals were 16% more likely to require continuous renal replacement therapy during hospitalization.

Seyltx Advances Chronic Cough Pipeline with Optimized Ifenprodil Dosing and Strategic NeurOp Partnership

Non-human primate studies reveal that increasing Ifenprodil doses from 20 mg to 40-80 mg could achieve 60-80% receptor occupancy, significantly enhancing therapeutic effects for chronic cough treatment.

Brooklyn Health Raises $6.5M to Transform CNS Clinical Trial Measurement with AI-Powered Platform

Brooklyn Health secured $6.5 million in seed funding led by HealthX Ventures to advance its AI-powered clinical trial measurement technology for central nervous system disorders.

Yale's Experimental Cancer Vaccine Shows Remarkable Success in Canine Clinical Trials

A novel cancer vaccine developed at Yale University has demonstrated promising results in canine clinical trials, with multiple dogs showing complete tumor regression after treatment.

Lenacapavir and Broadly Neutralizing Antibodies Show Promise as Twice-Yearly HIV Treatment

Phase II trial results demonstrate that lenacapavir combined with two broadly neutralizing antibodies (teropavimab and zinlirvimab) maintained viral suppression in 96% of participants over 26 weeks, comparable to daily oral regimens.

Novel Drug Combination Shows Promise Against KRAS-Mutated Lung Cancer Resistance

VCU Massey researchers discovered that combining FDA-approved sotorasib with experimental FGTI-2734 effectively overcomes resistance in KRAS G12C-mutated non-small cell lung cancer, potentially offering new hope for the 14% of patients with this mutation.

Ocean Biomedical's Novel Cancer Immunotherapy Shows Promise in Reversing EGFR-TKI Resistance in Lung Cancer

Ocean Biomedical's breakthrough research demonstrates their immunotherapy candidates can synergize with tyrosine kinase inhibitors like osimertinib to suppress tumor growth in EGFR-mutant lung cancer.

Study Reveals Significant Sleep Disruption Among Parents of Children with Atopic Dermatitis

National Health Interview Survey analysis shows 45.2% of parents with children having atopic dermatitis fail to get recommended 7 hours of sleep, compared to 37.1% of other parents.

PharmAla Biotech to Supply LaNeo MDMA for Yale University Clinical Trial

PharmAla Biotech has been contracted to supply its LaNeo MDMA for a clinical trial at Yale University, marking continued recognition in academic research.

West Virginia Approves Study Comparing Buprenorphine and Methadone for Opioid Use Disorder

West Virginia lawmakers passed a bill allowing clinical trials on opioid use disorder treatments, specifically comparing buprenorphine and methadone.

© Copyright 2025. All Rights Reserved by MedPath